Neurobiological Technolo... (EM)【NTII】銘柄情報

Neurobiological Technologies Inc (EM) (NTII) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.000001

( - )

買値

0.00

売値

0.00

出来高

0.00 日の範囲 0.00

0.000001 52 週間の範囲 0.0001

時価総額

27.02

前日終値

0.000001

始値

時刻

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

US$ 47,418

発行済株式数

27,019,805

配当利回り

PER

1 株当たり利益 (EPS)

0.69

歳入

25.32M

純利益

18.67M

Neurobiological Technologies, Inc. operates under a plan of liquidation and dissolution approved by stockholders in October 2009. Previously, it focused on developing investigational drugs for the treatment of human diseases. The company was founded in 1987 and is based in Emeryville, California. Neurobiological Technologies, Inc. operates under a plan of liquidation and dissolution approved by stockholders in October 2009. Previously, it focused on developing investigational drugs for the treatment of human diseases. The company was founded in 1987 and is based in Emeryville, California.

セクター

Healthcare

業界

Biotechnology & Life Sciences

本社

Emeryville, United States

設立

1987

Neurobiological Technologies Inc (EM) is listed in the Healthcare sector of the その他OTC with ticker NTII. The last closing price for Neurobiological Technolo... (EM) was US$0. Over the last year, Neurobiological Technolo... (EM) shares have traded in a share price range of US$ 0.000001 to US$ 0.0001.

Neurobiological Technolo... (EM) currently has 27,019,805 shares in issue. The market capitalisation of Neurobiological Technolo... (EM) is US$27.02 . Neurobiological Technolo... (EM) has a price to earnings ratio (PE ratio) of 0.00.

Neurobiological Technologies Announces Dividend of $0.05 Per Share

Neurobiological Technologies, Inc. (OTC Markets: NTII) (NTI or the Company) announced today that its board of directors has...

Celtic Pharma Announces Initiation of Pediatric Dose Tolerance Trial Evaluating XERECEPT(R) in Pediatric Patients with Primary a

Celtic Pharma Announces Initiation of Pediatric Dose Tolerance Trial Evaluating XERECEPT(R) in Pediatric Patients with Primary and Metastatic...

Neurobiological Technologies Announces Extraordinary Dividend of $0.18 per Share

Company also Announces Timing and Plans to Voluntarily Delist from the Nasdaq Capital Market and Initiate Dissolution Process EMERYVILLE, Calif...

Neurobiological Technologies Announces Stockholder Approval of Plan of Liquidation and Dissolution

Board of Directors Declares Extraordinary Dividend of $0.75 per share EMERYVILLE, Calif., Oct. 28 /PRNewswire-FirstCall/ -- Neurobiological...

Neurobiological Technologies Announces Intent to File Form 25 to Delist Common Stock From the NASDAQ Capital Market

EMERYVILLE, Calif., Oct. 19 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc. (NASDAQ:NTII) ("NTI") announced today it has submitted...

Neurobiological Technologies Receives Nasdaq Closing Bid Price Notification

EMERYVILLE, Calif., Sept. 17 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc. (NASDAQ:NTII) ("NTI") announced today that, on...

Neurobiological Technologies Reports Going Concern Qualification

EMERYVILLE, Calif., Sept. 19 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc. announced today that its financial statements for the...

Scimitar Equity Research Issues Q3/05 Review of Neurobiological Technologies, Inc.

Scimitar Equity Research Issues Q3/05 Review of Neurobiological Technologies, Inc. BOSTON, May 11 /PRNewswire-FirstCall/ -- Scimitar Equity...

Scimitar Equity Research Issues Review of Neurobiological Technologies, Inc.

Scimitar Equity Research Issues Review of Neurobiological Technologies, Inc. BOSTON, Aug. 20 /PRNewswire/ -- Scimitar Equity Research, Inc...

Conference Call Alert - Neurobiological Technologies, Inc. (Nasdaq: NTII)

Conference Call Alert - Neurobiological Technologies, Inc. (Nasdaq: NTII) RICHMOND, Calif., April 21 /PRNewswire-FirstCall/ -- Please join us...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	-9.9E-5	-99	0.0001	0.0001	1.0E-6	11855	1.0E-6	CS
26	0	0	1.0E-6	0.0001	1.0E-6	5380	1.0E-6	CS
52	-9.9E-5	-99	0.0001	0.0001	1.0E-6	224867	9.905E-5	CS
156	-0.000999	-99.9	0.001	0.001	1.0E-6	209303	9.179E-5	CS
260	-0.000499	-99.8	0.0005	0.008	1.0E-6	125288	0.00010903	CS